Soon NCB nod must for production, transport of two drugs

Image
Press Trust of India New Delhi
Last Updated : Mar 05 2013 | 9:00 PM IST
Cracking the whip on drug smuggling, the government is set to make it mandatory for anyone to get no-objection certificate from the Narcotics Control Bureau (NCB) for bulk production and transport of Ephedrine and Pseudoephedrine.
The two drugs are precursors for party drugs like Methamphetamine.
The Finance Ministry has decided that bulk production and transport of these two chemicals in the country will now be only be possible after obtaining a no-objection certificate from the central anti-drugs enforcement agency NCB.
"We are going to include Ephedrine and Pseudoephedrine in the new drug control regulation. Their bulk transport and use has to be cleared by the NCB now," Joint Secretary (Revenue) M L Meena said at the release of the annual report of the International Narcotics Control Board here.
Meena said the Department of Revenue has had consultations with the trade and industry bodies in this regard, and a fresh notification will be issued soon.
Anti-narcotics agencies and police departments have regularly flagged the menace posed by these drugs as they form the bulk of their seizures and interceptions in the mainland and along India's international borders with Pakistan, Bangladesh, Nepal, Bhutan and Myanmar.
While five narcotic drugs were under such a regulatory mechanism till now, the Ministry plans to include few more drugs under this list and as per accepted norms stipulated by the United Nations Office on Drugs and Crime (UNODC).
Meena said the Ministry, which has a dedicated Narcotics Control division, has also strengthened measures to regulate Codeine, an opiate which is used in cough syrup Phensedyl, notorious for its smuggling along the Bangladesh border.
The Finance Ministry is developing an online monitoring database for psychotropic substances in the country.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 05 2013 | 9:00 PM IST

Next Story